Arenas M D, Muñoz C, Sánchez-Payá J, Jover R, Egea J J, Gil M T, Martín F, Sarró F, Soriano A, Luna A, Olivares J, Reyes A, Muñoz del Bustillo E, del Pozo C, Valverde V, Perdiguero M, Araque A
Servicio de Nefrología del Sanatorio Perpetuo Socorro, Plaza Dr. Gómez Ulla, 15 03013 Alicante.
Nefrologia. 2001;21(6):581-7.
Hepatitis C virus (HCV) genotypes are irregularly distributed among the different geographic area and groups at risk.
To study the different HCV genotypes and subtypes of hemodialyzed patients from Alicante.
We studied 640 patients on haemodialysis (HD) and we determined the RNA-HCV and the genotypes in the 120 patients with antibodies against HCV (HCV-Ab). We compared the results with the genotypes of 1,370 patients from other groups at risk in the same geographic area.
RNA-HCV was not found in the serum in 15% (18/120) of the patients on HD who were HCV-Ab positive. Prevalence of the different genotypes in the 102 patients with positive viral RNA was the following: 1b: 56.8% (58/102), 1a: 19.6% (20/102), 3: 17% (17/102), 2a-2c: 1.9 (2/102), 2b: 0.9% (1/102) 4: 2.9 (3/102), 5: 0.9% (1/102). In conclusion, the genotype 1b was the most frequent in the patients studied in all these areas, and was the same as in the rest of the country. This genotype has been associated with the most severe hepatic disease and poor response to treatment, affecting the prognosis of these patients. The most frequent genotypes in HD in Alicante were 1b, 3 and 1a. HCV genotypes distribution among the HD units was not uniform in the different geographic areas. HCV genotypes distribution in the HD population is similar to other groups at risk from the same geographic area.
丙型肝炎病毒(HCV)基因型在不同地理区域和高危人群中分布不均。
研究阿利坎特血液透析患者的不同HCV基因型和亚型。
我们研究了640例血液透析(HD)患者,并在120例抗HCV抗体(HCV-Ab)阳性患者中检测了RNA-HCV和基因型。我们将结果与同一地理区域其他高危人群的1370例患者的基因型进行了比较。
在120例HCV-Ab阳性的HD患者中,15%(18/120)的患者血清中未检测到RNA-HCV。102例病毒RNA阳性患者中不同基因型的患病率如下:1b:56.8%(58/102),1a:19.6%(20/102),3:17%(17/102),2a-2c:1.9%(2/102),2b:0.9%(1/102),4:2.9%(3/102),5:0.9%(1/102)。总之,在所有这些地区研究的患者中,1b基因型最为常见,与该国其他地区相同。该基因型与最严重的肝病和治疗反应不佳有关,影响这些患者的预后。阿利坎特HD患者中最常见的基因型是1b、3和1a。不同地理区域HD单位中HCV基因型分布不均匀。HD人群中HCV基因型分布与同一地理区域的其他高危人群相似。